Injection for lowering cholesterol in high-risk patients
Part of Hormones & metabolism clinical trials.
This study tests an investigational injection, DNV001, for people with high cholesterol who are already on a statin. The goal is to see if the injection can further lower LDL ('bad') cholesterol when added to your current statin treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have high cholesterol (or mixed high cholesterol/triglycerides) and are already taking a statin. You must stay on the same statin dose during the study.
- Your fasting LDL (bad cholesterol) is at or above 70 mg/dL if you have history of heart disease, or at or above 100 mg/dL if you don't.
- Your fasting triglycerides (a type of fat in the blood) are below 400 mg/dL.
- You are willing to keep your diet and physical activity stable during the study.
- If you are a woman who could become pregnant or a man who has not had a vasectomy, you must use effective birth control during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medication called HST101 for lowering cholesterol in people who are already taking cholesterol pills but still have high levels. It may help if you have heart disease or are at high risk.
This trial tests a new medicine that aims to lower LDL (bad) cholesterol in healthy adults. It will help doctors understand how the medicine works in the body and how safe it is.
This study tests a new injection called ART002g1 for people with an inherited form of high cholesterol (heterozygous familial hypercholesterolemia). The goal is to see if it is safe and can help lower cholesterol levels.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
This study tests a new investigational medicine (QLC7401) that aims to lower LDL ('bad') cholesterol when added to your current cholesterol-lowering therapy. If you are already on a statin but your cholesterol is still not low enough, this trial might help you reach your goals.
This study tests a new medication called SYH2053 to see if it helps lower 'bad' cholesterol more effectively when added to your current statin therapy. It is for patients whose cholesterol is still not at their doctor's target level, and it aims to improve heart health.
Hear when a new Primary Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.